James J. Evans MD
Epilepsy Surgery, Pituitary Surgery, Skull Base, Stereotactic & Functional Neurosurgery
Associate Professor of Neurological Surgery, Thomas Jefferson University
1600 Rockland RoadWilmington, DE 19803
Overview of Dr. Evans
Dr. James Evans is a neurosurgeon in Wilmington, DE and is affiliated with multiple hospitals in the area, including Nemours Children’s Hospital, Delaware, Thomas Jefferson University Hospital, and Wills Eye Hospital. He received his medical degree from University of Massachusetts Medical School and has been in practice 31 years. Dr. Evans accepts several types of health insurance, listed below. He is one of 88 doctors at Thomas Jefferson University Hospital and one of 2 doctors at Wills Eye Hospital who specialize in Neurosurgery. He has more than 100 publications and over 500 citings.
Education & Training
Cleveland Clinic FoundationResidency, Neurological Surgery, 1996 - 2002- Cleveland Clinic FoundationInternship, Transitional Year, 1995 - 1996
University of Massachusetts Medical SchoolClass of 1995
Certifications & Licensure
DE State Medical License 2010 - 2027
NJ State Medical License 2021 - 2027
PA State Medical License 2003 - 2026
VA State Medical License 2002 - 2008
OH State Medical License 2000 - 2005
American Board of Neurological Surgery Neurological Surgery
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Allscripts TouchWorks EHR, Allscripts, 2012, 2014-2017
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR (Complete), Allscripts, 2012, 2014-2017
- CMS Meaningful Use Stage 1 Certification Allscripts TouchWorks EHR, Allscripts, 2012, 2014-2017
Clinical Trials
- Phase I Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma Start of enrollment: 2012 Nov 09
- Vemurafenib Combined With Whole Brain Radiation Therapy or Radiosurgery in Patients With BRAF Mutation-Positive Melanoma and Brain Metastases
- Alisertib and Fractionated Stereotactic Radiosurgery in Treating Patients With Recurrent High Grade Gliomas Start of enrollment: 2015 Jan 30
Publications & Presentations
PubMed
- Ki-67 ≥ 13% and Local Failure in WHO grade 2 and 3 Meningiomas: A Single-Institution Cohort Study.Anthony Yulin Chen, Aneesh Reddy, Toren Ikea-Mario, Shray Jain, Zhenghao Xiao
Journal of Clinical Neuroscience. 2026-10-01 - Molecular therapy for papillary craniopharyngioma: a multi-institutional analysis of practice patterns across the RAPID Consortium.Mark A Damante, Ryan B Juncker, Andrew S Little, Jamie J Van Gompel, Sandhya Palit
Journal of Neuro-Oncology. 2026-08-14 - 1 citationsEarly Findings from the Multicenter RAPID Consortium on Papillary Craniopharyngiomas.Michael P Catalino, Duy Pham, Robert C Rennert, William T Couldwell, James J Evans
Journal of Neurological Surgery. Part B, Skull Base. 2026-08-01
Press Mentions
Don't Delay Necessary Medical Care, Even During the COVID-19 PandemicSeptember 8th, 2020
Professional Memberships
- Member
- Fellow
- Member
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
AmeriHealth Direct POS
Amerihealth HMO
AmeriHealth PPO
BCBS Blue Card PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Coventry Carelink Health Plans PPO
First Health PPO
Great West PPO
HealthAmerica HealthAssurance PPO
Horizon BCBS Direct AccessHorizon BCBS HMO
Horizon BCBS POS
Horizon BCBS PPO
Humana ChoiceCare Network PPO
IBC Keystone HMO / POS
IBC Personal Choice PPO
Multiplan PHCS PPO
Multiplan PPO
Oxford Health Freedom
Oxford Health Liberty
QualCare HMO
QualCare PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
